entertainment -WSS

entertainment

author：hotspot 2025-09-29 19:59:53 - browse：78169

There’s a pharmacy in the White House — or, at least, there’s a sign that says “Pharmacy,” though the people in charge insist it isn’t one. Whatever they call it, the office has had enough internal complaints to warrant a government watchdog investigation.

And its findings were hardly encouraging:

One former pharmacy staff member told investigators that a doctor once asked if the staffer could “hook up” someone with a controlled substance “as a parting gift for leaving the White House.”
The office dispensed controlled medications like Ambien and Provigil without verifying the patient’s identity.
It let people grab over-the-counter medicines from open bins.
And upwards of $640,000 in taxpayer funds were wasted in just three years, though that number is fuzzy, because so many records were poorly kept and even handwritten.

The investigation, published this month, was conducted by the Department of Defense’s independent Office of the Inspector General; the White House pharmacy is run by the White House Military Office and its associated medical unit. The probe was prompted by complaints the Department of Defense received in 2018 about a senior military medical officer, who is not named, engaging in “improper medical practices.” It covers only activity in the office through early 2020 under the Trump administration, but investigators interviewed staffers who also worked there under former President Obama.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： For BCIs, commercial hurdles may be bigger than scientific ones

WSS

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Microsoft strikes partnership with Duke Health to advance health AI

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Nearly two

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

knowledge

entertainment

Wikipedia

Psychedelics group wrestles with new pharma identity

OTC birth control: A brief history of over the counter pill design

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Physician assistants need a new name. Here's what it should be

What does generative AI mean for health care? We asked experts

Allen Institute goes after foundational questions, CEO Costa says

Medicare details structure of new drug price negotiation program

Nonprofit, backed by Microsoft, to certify AI tools in health care

Hollywood unions extend contract negotiations for actors

'Ancient DNA,' 23andMe reveal African American ancestries

hotspot

Gene therapy denied for Afghan refugee whose father aided U.S.

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Profiling embryos to choose those with higher IQs is almost a reality

What the cancer research community can learn from the Covid response

Nonprofit, backed by Microsoft, to certify AI tools in health care

White House drug shortage group privately met with industry

focus

focus

knowledge

leisure time